First Trust Advisors’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-80,907
| Closed | -$174K | – | 2575 |
|
|
2022
Q2 | $174K | Buy |
80,907
+710
| +0.9% | +$1.53K | ﹤0.01% | 2407 |
|
|
2022
Q1 | $252K | Sell |
80,197
-4,655
| -5% | -$14.6K | ﹤0.01% | 2417 |
|
|
2021
Q4 | $272K | Buy |
84,852
+10,622
| +14% | +$34.1K | ﹤0.01% | 2406 |
|
|
2021
Q3 | $249K | Sell |
74,230
-35,950
| -33% | -$121K | ﹤0.01% | 2413 |
|
|
2021
Q2 | $431K | Buy |
110,180
+3,384
| +3% | +$13.2K | ﹤0.01% | 2310 |
|
|
2021
Q1 | $429K | Buy |
106,796
+8,573
| +9% | +$34.4K | ﹤0.01% | 2253 |
|
|
2020
Q4 | $227K | Buy |
98,223
+5,841
| +6% | +$13.5K | ﹤0.01% | 2256 |
|
|
2020
Q3 | $530K | Buy |
+92,382
| New | +$530K | ﹤0.01% | 2020 |
|